Detalhe da pesquisa
1.
Enapotamab Vedotin, an AXL-Specific Antibody-Drug Conjugate, Demonstrates Antitumor Efficacy in Patient-Derived Xenograft Models of Soft Tissue Sarcoma.
Int J Mol Sci
; 23(14)2022 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35886842
2.
Trametinib inhibits RAS-mutant MLL-rearranged acute lymphoblastic leukemia at specific niche sites and reduces ERK phosphorylation in vivo.
Haematologica
; 103(4): e147-e150, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29419436
3.
High-throughput drug screening reveals Pyrvinium pamoate as effective candidate against pediatric MLL-rearranged acute myeloid leukemia.
Transl Oncol
; 14(5): 101048, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33667892
4.
Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint Blockade.
Cancer Res
; 81(7): 1775-1787, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33531370
5.
Decitabine mildly attenuates MLL-rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo-sensitizer.
EJHaem
; 1(2): 527-536, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35844991
6.
Identification of genes transcriptionally responsive to the loss of MLL fusions in MLL-rearranged acute lymphoblastic leukemia.
PLoS One
; 10(3): e0120326, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25793396
7.
Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia.
Leukemia
; 34(11): 2898-2902, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32488115
8.
Targeted delivery of SiRNA to CD33-positive tumor cells with liposomal carrier systems.
J Control Release
; 144(2): 251-8, 2010 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20184933